People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SynapDx Corp. | — | Biotechnology | Series B | $24.7M | $609.2M | 2010 |
James J. Nahirny at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James J. Nahirny on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stanley N. Lapidus | 1 | 4 |
| Hemant J. Taneja | 1 | 3 |
| Robert J. Carpenter | 1 | 3 |
| Jeffrey R. Luber | 1 | 2 |
| William J. Geary | 1 | 2 |
| Andrew Peter Conrad | 1 | 1 |
| Thomas Peter Mac Mahon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.